ClinVar Miner

Submissions for variant NM_005902.4(SMAD3):c.1091A>G (p.Tyr364Cys)

dbSNP: rs886039177
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000766262 SCV000320481 likely pathogenic Familial thoracic aortic aneurysm and aortic dissection 2020-04-07 criteria provided, single submitter clinical testing The p.Y364C variant (also known as c.1091A>G), located in coding exon 8 of the SMAD3 gene, results from an A to G substitution at nucleotide position 1091. The tyrosine at codon 364 is replaced by cysteine, an amino acid with highly dissimilar properties. This alteration has been detected in several patients with vascular disease and has been reported to segregate with disease in one family (Schepers D et al. Hum. Mutat., 2018 05;39:621-634; Renner S et al. Genet. Med., 2019 08;21:1832-1841; Ambry internal data; B. Loeys pers. comm.). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic.
Institute of Human Genetics, University Medical Center Hamburg-Eppendorf RCV000766262 SCV000897682 likely pathogenic Familial thoracic aortic aneurysm and aortic dissection 2018-11-20 criteria provided, single submitter clinical testing
Invitae RCV000766262 SCV002197920 uncertain significance Familial thoracic aortic aneurysm and aortic dissection 2024-01-29 criteria provided, single submitter clinical testing This sequence change replaces tyrosine with cysteine at codon 364 of the SMAD3 protein (p.Tyr364Cys). The tyrosine residue is highly conserved and there is a large physicochemical difference between tyrosine and cysteine. This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of SMAD3-related conditions (PMID: 29392890, 30675029). ClinVar contains an entry for this variant (Variation ID: 264500). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SMAD3 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.